Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
HCV Action and PHE hepatitis C roadshow in Newcastle: Presentations
On 17th May 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Newcastle. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Newcastle and the wider north east region.North East, UK, England Jun 2016 Other, Strategy & Planning PDF
HCV Action good practice case study: Waverley Care Self Management Programme
This good practice case study looks at the Waverley Care Self Management Programme. The programme involves the delivery of workshops to people with hepatitis C, which focus on issues such as self-identity, confidence, self-esteem, goal setting and problem solving, with the aim of supporting people with hepatitis C to make informed choices regarding their lifestyle choices and improve the knowledge that they have of their condition.
The case study explains details why the programme was established, how it works, and the outcomes that it has achieved.UK, Scotland Apr 2016 Case study PDF
HCV Action good practice case study: Positive Help support services
This good practice case study looks at the support services offered to people with hepatitis C in the Lothians by Positive Help. These services include a transport service which allows service users to attend appointments and stay engaged in the care pathway, as well as a service providing domestic help in service users' homes.
This case study details why the services were established, how they work, and the outcomes that they have achieved.UK, Scotland Apr 2016 Case study PDF
WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.UK, Rest of World Apr 2016 Other, Strategy & Planning PDF
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
This article provides analysis of the estimated impact of new treatment for hepatitis C on both the prevention of transmission of the virus, and on preventing hepatitis C-related liver disease.
It concludes that focusing treatment solely on people with cirrhosis is not a tenable long-term strategy if continued reductions in new cases of end stage liver disease and hepatocellular carcinoma, as well as reductions in transmission are to be achieved. It also finds that treatment of other groups will need to follow quickly if these reductions are to be achieved.England Apr 2016 Reports & Research PDF
Hepatitis C ODNs and Clinical Leads
Operational Delivery Networks (ODNs) are the new structures through which hepatitis C treatment in England is being delivered. The Network involves regional centres which manage treatment decisions and prescribing, and which have a dispersed treatment model which aims to support partnership working and access for local patients.
This graphic details each ODN across England, along with the named ODN Clinical Lead for each.England Apr 2016 Other, Strategy & Planning PDF
Guidance: Hepatitis C prevention, diagnosis and treatment in prisons in England
This document, published by The Hepatitis C Trust after convening an expert group of prison healthcare commissioners and practitioners, provides commissioners and prison healthcare teams with practical guidance regarding the implementation of opt-out BBV testing and related hepatitis C care pathways, which can be adapted and used by any prison that needs to develop, revise or update their services.UK, England Mar 2016 Reports & Research, Tools & Templates, Strategy & Planning PDF
The blood borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation
In recognition of the exceptionally high prevalence of blood borne viruses (BBVs), in particular hepatitis C, amongst people in prisons and previously very low rates of testing, in October 2013 Public Health England (PHE), NHS England and the National Offender Management Service (NOMS) agreed to introduce opt-out testing for hepatitis B, hepatitis C and HIV across the prison estate by 2016/17.UK, England Mar 2016 Reports & Research, Strategy & Planning PDF
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
This article uses the example of Switzerland to look at how recent developments in hepatitis C therapy might impact upon the prevention of hepatitis C vertical (i.e. mother to baby) transmission. It finds that universal screening for hepatitis C among pregnant women should be urgently re-evaluated in the light of the new treatments which are now available.Rest of World Feb 2016 Reports & Research PDF
Building the Momentum: Making the Case: World Hepatitis Summit 2015 meeting report
On 2nd - 4th September 2015 in Glasgow, the World Hepatitis Alliance staged the first ever World Hepatitis Summit in conjunction with the World Health Organisation and the Scottish Government. Over eighty countries were represented at the Summit which brought together delegates from national governments, World Hepatitis Alliance member organisations, public health and the pharmaceutical industry.Rest of World Feb 2016 Reports & Research, Strategy & Planning PDF